Mucocutaneous Leishmaniasis
3 clinical trials · Condition
◉ Watch Mucocutaneous Leishmaniasis
| Record | Firm | Date |
|---|---|---|
| Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis (NCT02429518) | Knight Therapeutics (USA) Inc | 2015-12-01 |
| Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis (NCT02431429) | Knight Therapeutics (USA) Inc | 2015-07-01 |
| Low Antimonial Dosage in American Mucosal Leishmaniasis (NCT01301937) | Oswaldo Cruz Foundation | 2008-10-01 |
Track Mucocutaneous Leishmaniasis automatically
Every clearance here is in the API, with alerts when new ones post.